Fast Locator 2013-2014: Baxter - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2013-2014: Baxter


Untitled Document

Baxter (BioPharm Solutions)
One Baxter Parkway, DF4-3W
Deerfield, Illinois 60015

Regions served:
Asia
North America
Europe

Description:
Sterile Contract Manufacturing
With over 80 years of parenteral experience, BioPharma Solutions (a business unit of Baxter) offers a variety of contract manufacturing form/fill/finish services and solutions for injectables, designed to meet complex and traditional sterile manufacturing challenges. In addition, we are the only CMO to offer a manufacturer-prepared, commercial-scale aseptic filling process for premixed drugs in flexible IV bags. BioPharma Solutions provides our clients with confidence of delivery, service, and integrity - we know the work we do is ultimately vital to the patients you serve.

Website
www.baxterbiopharmasolutions.com

Services Provided:

Biomanufacturing
Vaccines

Formulation Development & Phase I/II Clinical Trial Materials (CTM)
Injectable products development

Packaging and Logistics
Commercial packaging

Commercial Manufacturing
Injectables manufacturing
Active Pharmaceutical Ingredients (API) manufacturing – (cGMP, large molecules/biologics)
Active Pharmaceutical Ingredients (API) and advanced intermediates manufacturing – (cGMP, small molecule)

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here